0001209191-23-049093.txt : 20230912
0001209191-23-049093.hdr.sgml : 20230912
20230912161927
ACCESSION NUMBER: 0001209191-23-049093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230911
FILED AS OF DATE: 20230912
DATE AS OF CHANGE: 20230912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zak Lourie S.
CENTRAL INDEX KEY: 0001991207
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41599
FILM NUMBER: 231250302
MAIL ADDRESS:
STREET 1: C/O GENELUX CORPORATION
STREET 2: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENELUX Corp
CENTRAL INDEX KEY: 0001231457
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: 805-267-9889
MAIL ADDRESS:
STREET 1: 2625 TOWNSGATE ROAD, SUITE 230
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: GENELUX CORP
DATE OF NAME CHANGE: 20030508
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-11
0
0001231457
GENELUX Corp
GNLX
0001991207
Zak Lourie S.
C/O GENELUX CORPORATION
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE
CA
91361
0
1
0
0
Chief Financial Officer
0
Stock Option (right to buy)
22.40
2023-09-11
4
A
0
150000
0.00
A
2033-09-10
Common Stock
150000
150000
D
25% of the shares shall vest on September 11, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.
/s/ Sean Ryder, Attorney-in-Fact
2023-09-12